ATE276267T1 - Röntgendiagnostika - Google Patents

Röntgendiagnostika

Info

Publication number
ATE276267T1
ATE276267T1 AT01944795T AT01944795T ATE276267T1 AT E276267 T1 ATE276267 T1 AT E276267T1 AT 01944795 T AT01944795 T AT 01944795T AT 01944795 T AT01944795 T AT 01944795T AT E276267 T1 ATE276267 T1 AT E276267T1
Authority
AT
Austria
Prior art keywords
regions
radioimaging
probes
ldl
tissues
Prior art date
Application number
AT01944795T
Other languages
English (en)
Inventor
Hu Liu
Lili Wang
Wu Xiao
Original Assignee
Genesis Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genesis Group Inc filed Critical Genesis Group Inc
Application granted granted Critical
Publication of ATE276267T1 publication Critical patent/ATE276267T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/0493Steroids, e.g. cholesterol, testosterone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Optical Head (AREA)
  • Drying Of Semiconductors (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT01944795T 2000-06-08 2001-06-08 Röntgendiagnostika ATE276267T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA2311209 2000-06-08
PCT/CA2001/000822 WO2001093918A2 (en) 2000-06-08 2001-06-08 Radioimaging probes and the use thereof

Publications (1)

Publication Number Publication Date
ATE276267T1 true ATE276267T1 (de) 2004-10-15

Family

ID=4166453

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01944795T ATE276267T1 (de) 2000-06-08 2001-06-08 Röntgendiagnostika

Country Status (8)

Country Link
US (1) US20030194372A1 (de)
EP (1) EP1287016B1 (de)
AT (1) ATE276267T1 (de)
AU (1) AU2001267193A1 (de)
CA (1) CA2411586A1 (de)
DE (1) DE60105596T2 (de)
ES (1) ES2227221T3 (de)
WO (1) WO2001093918A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE382033T1 (de) * 2001-08-23 2008-01-15 Fujifilm Corp 1,3-glyceridverbindung mit zwei iodphenylgruppen
WO2008101173A2 (en) * 2007-02-16 2008-08-21 Cornell University Biodegradable compositions and materials
WO2017187343A2 (en) * 2016-04-29 2017-11-02 Thome Kreutz Fernando Nanoemulsions and methods for cancer therapy
CN116908335B (zh) * 2023-08-25 2025-09-26 遂成药业股份有限公司 一种高效液相色谱法检测卤代植物醇含量的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4933157A (en) * 1988-06-27 1990-06-12 The University Of Michigan Radioiodinated arylaliphatic ether analogues of cholesterol
NO940115D0 (no) * 1994-01-13 1994-01-13 Nycomed Imaging As Kontrastmidler for roentgen- og magnettomografisk avbildning
AU5187696A (en) * 1995-03-09 1996-10-02 Nanosystems L.L.C. Nanoparticulate diagnostic triiodo benzoate derivatives as x-ray contrast agents for blood pool and lymphatic system imaging

Also Published As

Publication number Publication date
DE60105596D1 (de) 2004-10-21
EP1287016A2 (de) 2003-03-05
AU2001267193A1 (en) 2001-12-17
ES2227221T3 (es) 2005-04-01
WO2001093918A3 (en) 2002-08-01
EP1287016B1 (de) 2004-09-15
CA2411586A1 (en) 2001-12-13
DE60105596T2 (de) 2005-09-22
US20030194372A1 (en) 2003-10-16
WO2001093918A2 (en) 2001-12-13

Similar Documents

Publication Publication Date Title
García-Godoy et al. Effect of bleaching gels on the surface roughness, hardness, and micromorphology of composites
MX355683B (es) Composiciones farmacéuticas de paclitaxel, análogos de paclitaxel o conjugados de paclitaxel, y métodos relacionados de preparación y uso.
EP2044960A3 (de) Phospholipid-Analoga für die Behandlung und die Diagnose von Krebs
CR10169A (es) "uso de derivados de sulfamida heterociclica benzo-fusionada para disminuir lipidos y disminuir niveles de glucosa en la sangre"
IS2522B (is) Mótefni fyrir ED-B-hneppi fibrónektíns, samsetningar, sem innihalda þau, og notkun þeirra til þess að sjúkdómsgreina og til þess að meðhöndla æxli og sjúkdóma, sem tengjast æðanýmyndun
HUP0301405A2 (hu) Fokozott oldékonyságú gyógyhatású komponenseket tartalmazó készítmények
IL186741A0 (en) Optical probe for delivery of light
EA200602077A1 (ru) Активируемые частицы, их получение и применение
CL2009000555A1 (es) Compuestos derivados de tetramatos sustituidos espirociclicamente con 4'4'-dioxaespiro; procedimiento de preparacion; agente para combatir plagas y/o vegetaciones indeseadas que comprende dichos compuestos; su procedimiento de preparacion y uso; composiciones y su uso
MXPA04000173A (es) Compuestos basados en peptidos.
SG158175A1 (en) Lipid complexes coated with peg and their use
AU5068301A (en) Peptide-based compounds
BRPI0907970A8 (pt) composição para tratamento dos cabelos ou pelos e método para aumentar o diâmetro dos cabelos ou pelos
BRPI0408547A (pt) formulação para um inalador com dosador usando hidro-flúor-alcanos como propelentes
EA200601524A1 (ru) Альфа-излучающие частицы гидроксиапатита
BRPI0619522B8 (pt) conjugados de objetivação de vetor-fosfolipídio, composição compreendendo os referidos conjugados, composição de agente de contraste para ultra-som e método para preparo de microvesícula cheia de gás compreendendo um fosfolipídio e de fabricação de conjugado de peptídeo-fosfolipídio tendo baixos níveis de tfa
WO2006090389A3 (en) Novel diagnostic markers, especially for in vivo imaging, and assays and methods of use thereof
WO2007079202A3 (en) Treatment for acute lymhoblastic leukemia
DE602006008135D1 (de) Metallchelate von makrocyclischen polyaminocarbonsäurederivaten und deren anwendung bei der diagnostischen bilderzeugung
UY27027A1 (es) Kit de repinotano
MX2009005855A (es) Formulaciones inhalables de bisfosfonato enlazado con polimero y metodos de uso de las mismas.
ATE276267T1 (de) Röntgendiagnostika
WO2003086474A3 (en) Fluorinated or paramagnetic alginate polymer, annexin paramagnetic conjugate, and their use as contrasting agent in mri
DE60111917D1 (de) Lyophilisierbares Kontrastmittel, gasgefüllte Mikrobläschen enthaltend
BRPI0518328A2 (pt) agente de contraste, composiÇço farmacÊutica, uso de um agente de contraste, mÉtodo para gerar imagens realÇadas de um corpo animal ou humano, e, kit para a preparaÇço de um composiÇço radiofarmacÊutica

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1287016

Country of ref document: EP

REN Ceased due to non-payment of the annual fee